Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88

British Journal of Nutrition

Volumn 95, Issue 6, 2006, Pages 1177-1184

  Roselli, Marianna ^a   Finamore, Alberto ^a   Britti, Maria Serena ^a   Mengheri, Elena ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

Adhesion; Inflammation associated response; Intestinal cells; Neutrophil migration; Probiotics

Indexed keywords

CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 1BETA; INTERLEUKIN 8; ONCOPROTEIN; PROBIOTIC AGENT; PROTEINASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BIFIDOBACTERIUM ANIMALIS; CELL ADHESION; CELL CULTURE; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME DEGRADATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; INTESTINE CELL; INTESTINE INFECTION; LACTOBACILLUS RHAMNOSUS; NEUTROPHIL CHEMOTAXIS; SUPERNATANT; UPREGULATION;

BACTERIAL ADHESION; BIFIDOBACTERIUM; CACO-2 CELLS; CELLS, CULTURED; CHEMOKINES, CXC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-1; INTERLEUKIN-8; INTESTINES; LACTOBACILLUS RHAMNOSUS; NEUTROPHIL INFILTRATION; NEUTROPHILS; PROBIOTICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA;

BIFIDOBACTERIUM ANIMALIS; ESCHERICHIA COLI; LACTOBACILLUS RHAMNOSUS;

EID: 33745616069     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1079/BJN20051681     Document Type: Article

References (58)

1. Abbott A (2004) Gut reaction. Nature 427, 284-286.
2. Baggiolini M, Loetscher P & Moser B (1995) Interleukin-8 and the chemokine family. Int J Immunopharmacol 17, 103-108.
3. Berin MC, Darfeuille-Michaud A, Egan LJ, Miyamoto Y & Kagnoff MF (2002) Role of EHEC 0157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell Microbiol 4, 635-648.
4. Berkes J, Viswanathan VK, Savkovic SD & Hecht G (2003) Intestinal epithelial responses to enteric pathogens: Effects on the tight junction barrier, ion transport, and inflammation. Gut 52, 439-451.
5. Bernet MF, Brassart D, Neesr JR & Servin AL (1994) Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35, 483-489.
6. Dieleman LA, Goerres MS, Arends A, Sprengers D, Torrice C, Hoentjen F, Grenther WB & Sartor RB (2003) Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 52, 370-376.
7. Dotan I & Rachmilewitz D (2005) Probiotics in inflammatory bowel disease: Possible mechanisms of action. Curr Opin Gastroenterol 21, 426-430.
8. Elliott SN & Wallace JL (1998) Neutrophil-mediated gastrointestinal injury. Can J Gastroenterol 12, 559-568.
9. Finamore A, Roselli M, Merendino N, Nobili F, Vignolini F & Mengheri E (2003) Zinc deficiency suppresses the development of oral tolerance in rats. J Nutr 133, 191-198.
10. Forestier C, De Champs C, Vatoux C & Joly B (2001) Probiotic activities of Lactobacillus casei rhamnosus: In vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol 152, 167-173.
11. Gewirtz AT, Liu Y, Sitaraman SV & Madara JL (2002) Intestinal epithelial pathobiology: Past, present and future. Best Pract Res Clin Gastroenterol 16, 851-867.
12. Gill HS (2003) Probiotics to enhance anti-infective defences in the gastrointestinal tract. Best Pract Res Clin Gastroenterol 17, 755-773.
13. Gorbach SL (2000) Probiotics and gastrointestinal health. Am J Gastroenterol 95, S2-S4.
14. Granato D, Perotti F, Masserey I, Rouvet M, Golliard M, Servin A & Brassart D (1999) Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells. Appl Environ Microbiol 65, 1071-1077.
15. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 8, 512-519.
16. Haller D, Bode C, Hammes WP, Pfeifer AMA, Schiffrin EJ & Blum S (2000) Non pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leukocyte co-cultures. Gut 47, 79-87.
17. low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteria. Microbiol Immunol 46, 195-205.
18. Hampson DJ (1994) Postweaning Escherichia coli diarrhoea in pigs. In Escherichia coli in Domestic Animals and Humans, pp. 171-191 [CL Gyles, editor]. Wallingford, UK: CAB International.
19. Hidemura A, Saito H, Fukatsu K, Matsuda T, Kitayama J, Ikeda S, Kang W & Nagawa H (2003) Oral administration of Bifidobacterium longum culture condensate in a diet-restricted murine peritonitis model enhances polymorphonuclear neutrophil recruitment into the local inflammatory site. Nutrition 19, 270-274.
20. Ibnou-Zekri N, Blum S, Schiffrin EJ & von der Weid T (2003) Divergent patterns of colonisation and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71, 428-436.
21. Jarai G, Sukkar M, Garrett S, Duroudier N, Westwick J, Adcock I & Chung KF (2004) Effects of interleukin- 1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol 497, 255-265.
22. Jaye DL & Parkos CA (2000) Neutrophil migration across intestinal epithelium. Ann NY Acad Sci 915, 151-161.
23. Jenkins B, Holsten S, Bengmark S & Martindale R (2005) Probiotics: A practical review of their role in specific clinical scenarios. Nutr Clin Pract 20, 262-270.
24. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C & Madsen K (2004) DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126, 1358-1373.
25. Jin LZ, Marquardt RR & Zhao X (2000) A strain of Enterococcus faecium (18C23) inhibits adhesion of enterotoxigenic Escherichia coli K88 to porcine small intestine mucus. Appl Environ Microbiol 66, 4200-4204.
26. Jin LZ & Zhao X (2000) Intestinal receptors for adhesive fimbriae of enterotoxigenic Escherichia coli (ETEC) K88 in swine - a review. Appl Microbiol Biotechnol 54, 311-318.
27. Keates S, Keates AC, Mizoguch E, Bhan A & Kelly CP (1997) Enterocytes are the primary source of the chemokine ENA-78 in normal colon and in ulcerative colitis. Am J Physiol 273, G75-G82.
28. Kim HY, Kim HJ, Min HS, Kim S, Park WS, Park SH & Chung DH (2005) NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor betal production. J Exp Med 3, 41-47.
29. Lehto EM & Salminen SJ (1997) Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: Only a pH effect? FEMS Immunol Med Microbiol 18, 125-132.
30. Lievin-Le Moal V, Amsellem R, Servin AL & Coconner MH (2002) Lactobacillus acidophilus (strain LB) from the resident adult human gastrointestinal microflora exerts activity against brush border damage promoted by a diarrhoeagenic Escherichia coli in human enterocyte-like cells. Gut 50, 803-811.
31. Lugering N, Kucharzik T, Gockel H, Sorg C, Stoll R & Domschke W (1998) Human intestinal epithelial cells down-regulate IL-8 expression in human intestinal microvascular endothelial cells; role of transforming growth factor-beta 1 (TGF-beta1). Clin Exp Immunol 114, 377-384.
32. Majamaa H & Isolauri E (1997) Probiotics: A novel approach in the management of food allergy. J Allergy Clin Immunol 99, 179-185.
33. Majamaa H, Isolauri E, Saxelin M & Vesikari T (1995) Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 203, 333-338.
34. Marteau PR, de Vrese M, Cellier CJ & Schrezentneir J (2001) Protection from gastrointestinal disease with use of probiotics. Am J Clin Nutr 73, 430S-436S.
35. Mengheri E, Nobili F, Vignolini F, Pesenti M, Brandi G & Biavati B (1999) Bifidobacterium animalis protects intestine from damage induced by zinc deficiency in rats. J Nutr 129, 2251-2257.
36. Mercenier A, Pavan S & Pot B (2003) Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 9, 175-191.
37. Michail S & Abernathy F (2003) Lactobacillus plantartan inhibits the intestinal epithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr 36, 385-391.
38. Nagmeni CN, Detrick B & Hooks JJ (2002) Transforming growth factor-beta expression in human retinal pigment epithelial cells is enhanced by Toxoplasma gondii: A possible role in the immunopathogenesis of retinochoroiditis. Clin Exp Immunol 128, 372-378.
39. Neish AS (2002) The gut microflora and intestinal epithelial cells: A continuing dialogue. Microbes Infect 4, 309-317.
40. Neutra M & Louvard D (1989) Differentiation of intestinal cells in vitro. Mol Cell Biol 8, 363-398.
41. O'Sullivan GC, Kelly P, O'Halloran S, Collins C, Collins JK, Dunne C & Shanahan F (2005) Probiotics: An emerging therapy. Curr Pharm Des 11, 3-10.
42. Otte JM, Cario E & Podolsky DK (2004) Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol 286, G613-G626.
43. Ouwehand AC, Salminen S & Isolauri E (2002) Probiotics: An overview of beneficial effects. Antonie Van Leeuwenhoek 82, 279-289.
44. Parkos CA, Delp C, Arnaout MA & Madara JL (1991) Neutrophil transmigration across a cultured intestinal epithelium. J Clin Invest 88, 1605-1612.
45. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Diaz-Ropero MP, Olivares M, Xaus J, Zarzuelo A & Galvez J (2005) Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 11, 5185-5192.
46. Resta-Lenert S & Barrett KE (2003) Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52, 988-997.
47. Rollins BJ (1997) Chemokines. Blood 90, 909-928.
48. Roselli M, Finamore A, Garaguso I, Britti MS & Mengheri E (2003) Zinc oxide protects cultured enterocytes from the damage induced by Escherichia coli. J Nutr 133, 4077-4082.
49. Rudack C, Maune S, Eble J & Schroeder JM (2003) The primary role in biologic activity of the neutrophil chemokines IL-8 and GROalpha in cultured nasal epithelial cells. J Interferon Cytokine Res 23, 113-123.
50. Savkovic SD, Koutsouris A & Hecht G (1996) Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils. Infect Immun 64, 4480-4487.
51. Schroder JM (2000) Chemoattractants as mediators of neutrophilic tissue recruitment. Clin Dermatol 18, 245-263.
52. Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S & Rachmilewitz D (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 8, 399-406.
53. Smith DL, Harris AD, Johnson JA, Silbergeld EK & Morris GM (2002) Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. PNAS 99, 6434-6439.
54. Szekanecz Z, Strieter RM, Kunkel SL & Koch AE (1998) Chemokines in rheumatoid arthritis. Springer Semin Immunopathol 20, 115-132.
55. Teitelbaum JE & Walker WA (2002) Nutritional impact of pre and probiotics as protective gastrointestinal organisms. Annu Rev Nutr 22, 107-138.
56. Vaughan EE, de Vries MC, Zoetendal EG, Ben-Amor K, Akkermans AD & de Vos WM (2002) The intestinal LABs. Antonie Van Leeuwenhoek 82, 341-352.
57. Walz A, Stricter RM & Schnyder S (1993) Neutrophil-activating peptide ENA-78. Adv Exp Med Biol 351, 129-137.
58. Zhou JS, Pillidge CJ, Gopal PK & Gill HS (2005) Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains. Int J Food Microbiol 98, 211-217.